Gambaran Tatalaksana Pasien Preeklampsia yang Terkonfirmasi COVID-19 dan Non COVID-19 di RSUD Ulin Banjarmasin. Tinjauan Terhadap Pemberian MgSO4, Antihipertensi, Waktu dan Cara Terminasi Kehamilan Periode Mei 2020-Juni 2021

Abstract

Preeclampsia is hypertension in pregnancy which is characterized with blood pressure of 140/90 mmHg after 20 weeks of gestation, accompanied by proteinuria.3. There are three types of drugs that are often used in preeclampsia treatment, they are nifedipine, methyldopa, and MgSO4. This study was aimed to find out the descriptionof confirmed covid-19 and non covid-19 preeclampsia patients treatment at Ulin Hospital, Banjarmasin in the COVID-19 period seen from administration of MgSO4, antihypertensive, method and time of termination. This study applied descriptive method withdata collection throughmedical records. The sampling technique used purposive sampling which was selected based on the criteria. In this study, asample of 176 preeclampsia patients with confirmed COVID-19 and non-COVID-19 were obtained. However, from the 176 samples, which met the criteria, only 55 preeclampsia patients had confirmed COVID-19 and 80 non-COVID-19 preeclampsia patients. The results showed that all severe preeclampsia patients with confirmed COVID-19 were given MgSO4with a percentage of 100%.. Antihypertensives were often given was a combination of methyldopa + nifedipine. The most common method of delivery was by cesarean section